Impact ledger
Pacific Biosciences of California, Inc. (PACB): the developments shaping its investment case
Follow the evidence affecting Pacific Biosciences of California, Inc.. Review the key developments below. Continue in Market Ontology to test your assumptions, examine related opportunities, and save the investment case you want to track.
Research Pacific Biosciences of California, Inc. · $399/mo
Test assumptions, examine opportunities, and save your research.
Material developments
2026-09-20
Twist Bioscience Surges 31% on Eli Lilly AI Drug Discovery Deal
Channel: Increased investor interest in genomics/synthetic biology tools, potential for similar partnerships.
watch· 3-12m
2026-09-19
Twist Bioscience Partners with Eli Lilly on AI-Powered TuneLab Platform
Channel: Increased investor attention on companies leveraging AI/computational biology in life sciences, potential for similar partnerships.
watch· 3-12m
2026-09-25
Ginkgo Bioworks Inks $31M Contract with SaponiQx for AI Vaccine Adjuvants
Channel: Increased demand for genomic sequencing and synthetic biology tools and consumables as the sector grows and secures more funding.
Bullish· 3-12m
Event impact log
3 events mapped to PACB since 2026-09-19. Evidence through 2026-09-25.
| Date | Event | Channel | Direction | Horizon | Impact |
|---|---|---|---|---|---|
| 2026-09-25 | Ginkgo Bioworks Inks $31M Contract with SaponiQx for AI Vaccine Adjuvants | Increased demand for genomic sequencing and synthetic biology tools and consumables as the sector grows and secures more funding. | Bullish | 3-12m | 0.20 |
| 2026-09-20 | Twist Bioscience Surges 31% on Eli Lilly AI Drug Discovery Deal | Increased investor interest in genomics/synthetic biology tools, potential for similar partnerships. | watch | 3-12m | 0.30 |
| 2026-09-19 | Twist Bioscience Partners with Eli Lilly on AI-Powered TuneLab Platform | Increased investor attention on companies leveraging AI/computational biology in life sciences, potential for similar partnerships. | watch | 3-12m | 0.30 |
Continue this research
Build your Pacific Biosciences of California, Inc. investment case. Continue from the evidence above, change the assumptions the developments move, and save the work to revisit as the case develops.
This ledger is regenerated from Market Ontology's public event pipeline. View the PACB entity page →